羟考酮
医学
癌症疼痛
剂型
麻醉
口服
癌症
药理学
内科学
类阿片
受体
作者
Koji Oda,Hidekazu Kamiyama,Yukiko Goda
出处
期刊:PubMed
日期:2015-01-01
卷期号:42 (1): 63-6
被引量:1
摘要
In switching from oraloxycodone to oxycodone injection, clinical guidelines recommend a conversion dose ratio of 0.75. However, in clinical sites, a higher dosage may be needed due to characteristics of cancer pain. In the present study, we investigated changing the dosage amount of oxycodone before and after switching from oraloxycodone administration to oxycodone injection in patients (n=14) who reported suffering from cancer pain. As a result, we found the ratio of the amount used after switching to be 0.91 ± 0.25 (mean ± SD) on the first day, increasing to 1.46 ± 0.48 on the fifth day. Our findings suggest that the dosage amount was the correct one for each patient's condition and also that adequate injection dosage to manage cancer pain was greater than that of calculated by the conversion ratio.
科研通智能强力驱动
Strongly Powered by AbleSci AI